Active substance

Results for the substance idarucizumab

1 result

About this active substance

Idarucizumab is a monoclonal antibody used as an antidote for dabigatran, an oral anticoagulant. It is indicated for the rapid reversal of dabigatran's anticoagulant effect in emergencies, such as uncontrolled bleeding or urgent surgical procedures.

The medication is administered intravenously, as directed by a doctor. Its effect is rapid and usually complete within minutes.

Side effects may include injection site reactions, fever, headache, or nausea. In rare cases, severe allergic reactions may occur.

Idarucizumab is not recommended for patients with hypersensitivity to this medication or human-derived proteins.